lobbying_activities: 3045955

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id filing_uuid filing_type registrant_name registrant_id client_name filing_year filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
3045955 399459e8-3755-4d93-b58a-d367f5f909f2 Q3 RED+BLUE STRATEGIES 400693064 CAMBIA HEALTH SOLUTIONS (FORMERLY KNOWN AS THE REGENCE GROUP) 2023 third_quarter MMM H.R. 3561 - The PATIENT Act of 2023 - Issues related to Plans and PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the Medicare program. H.R. 5378 - Lower Costs, More Transparency Act of 2023 - Issues related to plans and PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the Medicare program. S. 2973 - Modernizing and Ensuring PBM Accountability Act of 2023 - Issues related to Plans and PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the Medicare program. Issues related to the successful implementation of the Inflation Reduction Act with a focus on lowering prescription medication prices in the Medicare program and ensuring affordable coverage options in the Marketplaces. HHS and CMS Rules and Regulations focused on the Medicare Advantage program including: CY 2024 Rate Announcement, CY 2024 Medicare Advantage technical rules. Issues related improving outcomes and access in mental and behavioral health in Medicare, Medicaid and the Marketplaces. Issues related to developing coherent prior authorization methodologies. Issues related to the Public Health Emergency and the impact that unwinding will have on individuals access to quality, affordable health care coverage in Medicaid and the Marketplaces. HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2023-10-07T14:53:06-04:00